In fiscal year 2025, Cencora's revenue by segment (products & services) are as follows:
Learn more about Cencora’s Revenue by Geography
Check out competitors to Cencora in a side-by-side comparison.
Explore additional financial metrics for Cencora.
| Animal Health | 5042549000 |
|---|---|
| International Healthcare Solutions | 27418679000 |
| Pharmaceutical Distribution | 229716669000 |
| Animal Health | 5365518000 |
|---|---|
| International Healthcare Solutions | 28627542000 |
| Pharmaceutical Distribution | 259973909000 |
| Animal Health | 5694517000 |
|---|---|
| International Healthcare Solutions | 30366323000 |
| Pharmaceutical Distribution | 285287506000 |
The above chart shows Cencora's revenue percentage share by segment (products and services).
In fiscal year 2023, Cencora's revenue by segment is as follows:
The above chart shows Cencora's revenue percentage share by segment (products and services).
In fiscal year 2024, Cencora's revenue by segment is as follows:
The above chart shows Cencora's revenue percentage share by segment (products and services).
In fiscal year 2025, Cencora's revenue by segment is as follows:
| Products & Services (Percent Share) | 2023 | 2024 | 2025 |
|---|---|---|---|
| International Healthcare Solutions | 10.46% | 9.74% | 9.45% |
| Animal Health | 1.92% | 1.83% | 1.77% |
| Pharmaceutical Distribution | 87.62% | 88.44% | 88.78% |
| Total Revenue | 100% | 100% | 100% |
The above chart shows the revenue trend of different segments of Cencora.
In fiscal year 2025, the Pharmaceutical Distribution generated the most revenue ($285.29 B), and the Animal Health generated the least revenue ($5.69 B).
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
| Products & Services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Animal Health | $5.04 B - |
$5.37 B
6.40%
|
$5.69 B
6.13%
|
| International Healthcare Solutions | $27.42 B - |
$28.63 B
4.41%
|
$30.37 B
6.07%
|
| Pharmaceutical Distribution | $229.72 B - |
$259.97 B
13.17%
|
$285.29 B
9.74%
|
| Total Revenue | $262.17 B - |
$293.96 B
12.12%
|
$321.33 B
9.31%
|